Ivy Clinical, Inc.
Ivy Clinical is a US business development consulting firm representing a network of 12+ independent clinical research sites across 8 states covering 14 therapeutic areas. The firm connects pharmaceutical companies and CROs with sites at no charge to sponsors, earning revenue through site-side contractual arrangements.
- Company typePrivate
- Founded2020
- Headquarters—
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Ivy Clinical, Inc. does
Ivy Clinical, Inc. is a privately held US business development consulting firm that represents a network of independent clinical research sites and acts as an intermediary between those sites and pharmaceutical companies and Contract Research Organizations (CROs). The company contracts directly with sites to exclusively represent their business development interests, with no charge to sponsors or CROs for its services; revenue is generated through contractual arrangements with the represented site network.
The firm's core offerings are organized into two service lines. Business Development Services encompass study lead generation across multiple therapeutic indications and trial phases, site selection management, site promotion and ongoing engagement with sponsors/CROs, ongoing study management from enrollment through completion, and pipeline generation of therapeutically aligned study opportunities. Consulting Services include complimentary operational/clinical protocol reviews and ballpark budgets for sponsors/CROs, growth and expansion consulting for sites entering new therapeutic areas, access to specialized outside consultants, patient recruitment resource evaluation, budget negotiation and RFI/RFP services, and individualized services tailored to site needs.
The underlying platform is not a technology product but a curated site network of 12+ independent clinical research sites spanning 8 US states (California, Arizona, Utah, Texas, Missouri, Illinois, Ohio, Georgia) and covering 14 therapeutic areas including psychiatry, psychedelics, substance use disorder, dermatology, endocrinology, cardiovascular disease, hepatic diseases, respiratory, neurology, sleep disorders, pain, rheumatology, and gastrointestinal disorders. The company is co-founded and led by Heidi M. Davis (EVP, Business Development; 25+ years industry experience) and Jerry Cruz (EVP, Business Operations; 30+ years across CROs, core labs, and investigational sites), with Jason Hovland as VP of Business Development and medical advisors Dr. Rick Mofsen and Dr. Mason Freeman providing scientific credibility. The firm maintains a low public footprint — a Squarespace website, a LinkedIn corporate page, and periodic news posts — and as of the most recent inputs has not raised institutional funding or disclosed revenue.
Ivy Clinical, Inc. firmographics
Firmographics- Name
- Ivy Clinical, Inc.
- Legal name
- Ivy Clinical, Inc.
- Website
- https://ivyclinical.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Ivy Clinical is a US business development consulting firm representing a network of 12+ independent clinical research sites across 8 states covering 14 therapeutic areas. The firm connects pharmaceutical companies and CROs with sites at no charge to sponsors, earning revenue through site-side contractual arrangements.
- Ownership category
- akta.pro rank
Ivy Clinical, Inc. industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
- akta.pro secondary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Ivy Clinical, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Business Development Consulting Services: IVY Clinical provides business development services to its network of clinical research sites. The company contracts directly with sites to exclusively represent their business development interests. No charge to sponsors or CROs for services. Revenue appears to be generated through management fees or contractual arrangements with the sites they represent.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Ivy Clinical, Inc. product offering
Product offeringCore offering
IVY Clinical is a business development consulting firm that contracts directly with a network of independent clinical research sites to exclusively represent their business development interests. The firm connects these sites with pharmaceutical companies and Contract Research Organizations (CROs) for clinical trial placement, providing study lead generation, site selection management, site promotion, ongoing study management, and pipeline generation — at no charge to sponsors or CROs.
Product overview
Ivy Clinical operates as a business development consulting firm offering a unified platform of services to its network of independent clinical research sites. The core offerings consist of Business Development Services (including study lead generation, site selection management, site promotion, ongoing study management, and pipeline generation) and Consulting Services (including protocol review, growth/expansion consulting, access to specialized consultants, patient recruitment resource evaluation, budget negotiation, and individualized services). The company represents a network of 13 independent clinical research sites across 8 U.S. states, collectively offering expertise across 14 therapeutic areas including psychiatry, psychedelics, substance use disorders, dermatology, endocrinology, cardiovascular disease, neurology, sleep disorders, pain, and more.
Differentiator
Problem solved
Functional benefit
Companies that use Ivy Clinical, Inc.
Customer profileSegments3 records
Ideal customer profiles3 records
Ivy Clinical, Inc. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ivy Clinical, Inc. partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Clinically MediacoreStrategic partnership aimed at combating patient recruitment challenges in clinical research. 86% of clinical studies fail to meet enrollment targets. The collaboration delivers customized, localized patient recruitment services leveraging Clinically Media's data-driven approach. Network sites gain access to larger central campaign-style recruitment initiatives without hefty costs. Partnership also focuses on diversifying clinical research participants and engaging with more representative patient groups.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
Ivy Clinical, Inc. competitors and assessment
Company assessmentBroad incumbents
- Syneos Health: Contract research organization with site management solutions and clinical trial services. Comparable as a broad incumbent offering site-management and recruitment capabilities as part of a wider CRO portfolio.
- IQVIA: Global CRO and clinical development services provider with dedicated site management, patient recruitment, and clinical operations offerings. Comparable as a broad incumbent whose SMO/patient-recruitment services overlap with IVY Clinical's intermediary role.
- Fortrea: Clinical development and site management services provider spun out of LabCorp Drug Development. Comparable as a broad incumbent whose site-management and patient-recruitment offerings overlap with IVY Clinical's intermediary function.
Emerging players
- Clincierge: Specializes in patient recruitment logistics, travel, and reimbursement support for clinical trial participants. Comparable as an emerging player addressing the patient-recruitment bottleneck that IVY Clinical's Clinically Media partnership also targets.
- ClinEdge: Patient recruitment and clinical trial services provider supporting site networks and sponsors. Comparable as an emerging player in the trial-enablement and patient-recruitment layer adjacent to IVY Clinical's services.
- Clinically Media: Data-driven patient recruitment services provider and IVY Clinical's 2023 strategic partner. Comparable as an emerging player in the patient-recruitment layer whose capabilities are now embedded in IVY Clinical's network offering.
Direct peers
- Elligo Health Research: Operates a 'Goes Direct' model that connects community-based clinical research sites with sponsors and CROs for trial placement. Most structurally comparable to IVY Clinical as an intermediary enabling site–sponsor connections rather than owning a site network itself.
- Velocity Clinical Research: Multi-therapeutic clinical research site network operating across the US. Comparable as a US site network serving diverse therapeutic areas and accepting trial placements from sponsors and CROs.
- Accel Research Sites: Network of clinical research sites across multiple US states and therapeutic areas. Comparable to IVY Clinical in providing sponsors a single point of access to a distributed site footprint.
- Benchmark Research: Multi-specialty site network conducting trials across therapeutic areas. Comparable as a US-based site network whose sponsor-facing value proposition overlaps with IVY Clinical's represented sites.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Ivy Clinical, Inc. social profiles
Digital presenceIvy Clinical, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ivy Clinical, Inc. leadership team
Management profileNumber of profiles
Profiles5 records
Ivy Clinical, Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ivy Clinical, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ivy Clinical, Inc.
What does Ivy Clinical, Inc. do?
IVY Clinical is a business development consulting firm that contracts directly with a network of independent clinical research sites to exclusively represent their business development interests. The firm connects these sites with pharmaceutical companies and Contract Research Organizations (CROs) for clinical trial placement, providing study lead generation, site selection management, site promotion, ongoing study management, and pipeline generation — at no charge to sponsors or CROs.
Is Ivy Clinical, Inc. a public or private company?
Ivy Clinical, Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ivy Clinical, Inc. founded?
Ivy Clinical, Inc. was founded in 2020. It employs 1 to 10 people.
How does Ivy Clinical, Inc. make money?
One revenue line is on record: business Development Consulting Services.
Who are Ivy Clinical, Inc.'s main competitors?
Broad incumbents on record are Syneos Health, IQVIA and Fortrea. Emerging players are Clincierge, ClinEdge and Clinically Media. Direct peers are Elligo Health Research, Velocity Clinical Research, Accel Research Sites and Benchmark Research.
Does Ivy Clinical, Inc. have an API?
No public API is recorded for Ivy Clinical, Inc..
What industry is Ivy Clinical, Inc. in?
Ivy Clinical, Inc.'s product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs, with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 54161 and its SIC code is 8742.